No Data
No Data
Adagene to Present at Investor Conferences in June
Adagene Inc. ("Adagene") (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced its participation in multiple investor conferences in June 2024.
Analysts Offer Insights on Healthcare Companies: EFFECTOR Therapeutics (EFTR), Adagene (ADAG) and Aquestive Therapeutics (AQST)
12 Health Care Stocks Moving In Monday's Intraday Session
GainersSunshine Biopharma (NASDAQ:SBFM) stock rose 86.3% to $0.11 during Monday's regular session. The company's market cap stands at $11.2 million. Xilio Therapeutics (NASDAQ:XLO) stock rose 25.93% t
Adagene Inc. Strikes Deal to Sell Depositary Shares
Adagene ADR Non-GAAP EPS of -$0.21, Revenue of $18.11M
Adagene's Breakthroughs Promise Future Growth
No Data